Submit Science – Scientific Sessions 2026

Trial timeline extending beyond the submission deadline?
Large clinical trials with the potential to significantly influence clinical practice may receive additional consideration. Contact [email protected] for more information.

American Heart Association Embargo Policies:

Clinical trial results are prohibited from being released until the date and time of the American Heart Association designated embargo time. For late-breaking science and featured science presentations, the embargo time is the date and time of the presentation at Scientific Sessions 2026. Clinical trial sponsors must comply with embargo guidelines established by the American Heart Association.

• Industry announcements required by the SEC (Security Exchange Commission) must be approved by the American Heart Association prior to release and any level of information released without approval will be considered an embargo break. Please reach out to Mary Lu Hare, [email protected] for more information or with any questions.